AdvaMed
  • Industry Updates
    • Research & Policy Papers
    • Policy Issues
    • Medtech POV Blog
    • Press Releases
    • Medtech POV Podcast
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events
    • In Person
    • Online
Login
stethoscope

Terumo Blood and Cell Technologies’ IMUGARD Platelet Pooling Set Cleared by FDA

RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable…

RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy

RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable…

UroMems Initiates First-in-Human Study of Its Smart Implant to Treat Stress Urinary Incontinence

UroMems announced today that it has successfully completed the first-in-human implant of the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) investigational device to treat SUI.

Workforce Inclusion & Diversity

TEAMFund Releases 4th Annual Impact Report, Announces Raise of $150M Fund, and Grants 5th Annual Global Health Innovation Award for Female-Founded Medtech Companies

TEAMFund, a 501(c)(3) Public Charity and a For-Profit Impact Fund whose mission is to enhance patient access to medical technology in low resource settings, announced at The AdvaMed Medtech Conference,…

Regulatory Affairs

Renovia Receives FDA Clearance for leva® Pelvic Health System as First-line Treatment for Chronic Fecal Incontinence

Renovia Inc., an AdvaMed member and developer of non-surgical, treatments for female pelvic floor disorders, announced the U.S. Food and Drug Administration (FDA) has cleared its leva® Pelvic Health System…

BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder Treatment

BlueWind Medical, Ltd., AdvaMed member and developer of the innovative RENOVA iStim™ implantable tibial neuromodulation (iTNM) device for treatment of Overactive Bladder, today announced the addition of Charles F. (“Chuck”)…

BlueWind Medical Ltd. Appoints Charles F. Cargile as Chief Financial Officer

BlueWind Medical, Ltd., AdvaMed member and developer of the innovative RENOVA iStim™ implantable tibial neuromodulation (iTNM) device for treatment of Overactive Bladder, today announced the addition of Charles F. (“Chuck”)…

Regulatory Affairs

Cook Medical receives FDA Breakthrough Device Designation for Zenith® Thoraco+ Endovascular System

AdvaMed member Cook Medical’s Zenith® Thoraco+ Endovascular System (Thoraco+) has received Breakthrough Device Designation from the US Food and Drug Administration (FDA).

Diagnostics / Global & Trade

Canadian Hospital Specialties Limited Joins AdvaMed, the World’s Leading Medical Technology Trade Association

February 9, 2022  — Canadian Hospital Specialties Limited (CHS) announced today that it has joined the Advanced Medical Technology Association (AdvaMed), the world’s leading trade association representing more than 400…

Global & Trade / Regulatory Affairs

B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site

Hyalex Orthopaedics, a privately-held medical device company developing transformational cartilage biomimetic products, today announced the appointment of Carl Vause as its new chief executive officer and president.

  • 1
  • 2
  • 3
  • Next
AdvaMed

Stay up to date with AdvaMed.

Subscribe for Updates
  • Member Center
  • Industry Updates
  • Contact
  • FAQs
  • Events
  • Careers
  • The Story of Medtech
  • The Medtech Conference
  • Because Every Moment Matters 

Copyright 2023 AdvaMed

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Accessibility Statement
  • 中文
  • youtube
  • linkedin
  • facebook
  • twitter
  • medium
  • instagram

Menu

  • Industry Updates
    • Research & Policy Papers
    • Policy Issues
    • Medtech POV Blog
    • Press Releases
    • Medtech POV Podcast
  • Member Center
    • Committees & Working Groups
    • Resource Library
    • Medtech Career Center
  • Events
    • In Person
    • Online
  • Login
  • About AdvaMed
    • Our Leadership
    • Initiatives
    • Jobs at AdvaMed
    • Contact Us
  • Membership & Join
    • Membership Directory
    • Associate Membership Directory
    • Membership Application
    • Lifetime Achievement Award
  • Medical Device Industry Facts
    • Safety & Quality
    • Job Creation
  • Technology & Regulatory Affairs
    • Pre-Market
    • Post-Market
  • Payment & Health Care Delivery Policy
    • Medicare Coverage and Payment Policy
    • Transitional Coverage of Emerging Technologies (TCET)
    • Diagnostic Tests Coding, Coverage, and Payment
    • Medtech Value Framework
  • Global Affairs
    • AdvaMed’s China Presence
  • Compliance & Ethics
    • Code of Ethics
  • Legal
    • Value-Based Collaborations
    • Civil Justice & Litigation Reform
    • Physician Payments Sunshine Act
  • Health Equity
  • AdvaMed Accel
    • Accel Member Directory
    • Partnerships and Opportunities
  • AdvaMedDx
    • AdvaMedDX Members
    • AdvaMedDx Resources
    • Join AdvaMedDX
  • Center for Digital Health
    • Center for Digital Health Members

Search